[New prospects in antirheumatic therapy. 3. Biometric evaluation of laboratory results in a multicentric research].
D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000188:drug therapy* / Q000201:enzymology; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D001786:Blood Glucose; D002986:Clinical Trials as Topic; D005069:Evaluation Studies as Topic; D005260:Female; D006454:Hemoglobins; D006801:Humans; D008297:Male; D008875:Middle Aged; D009098:Multiphasic Screening; D010003:Osteoarthritis / Q000097:blood / Q000188:drug therapy* / Q000201:enzymology; D011422:Propionates / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D001786:Blood Glucose; D006454:Hemoglobins; D011422:Propionates; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D001663:Bilirubin
Nuove prospettive in terapia antireumatica. 3. Valutazione biometrica delle risultanze di laboratorio in una ricerca multicentrica.